In addition to their antidiabetic effects, GLP-1R agonists have shown substantial benefits in promoting weight loss, largely through appetite suppression and delayed gastric emptying
Stopping GLP-1s leads to weight regain and inflammation, unless healthy habits support those changes. Why do insurance companies often deny coverage for GLP-1 medications
Whether for weight loss, cognitive support, inflammation reduction, or a blend of any/all of these, we are here to help
In this biopsychosocial context, GLP-1 RAs are best viewed not as a standalone solution, but as a facilitator of durable, self-directed change
Our bodies dont just run on thin air or potato chips, although itd be nice if they did
Almost nobody should pay that